Growth In Saudi Ngs Industry To Reach $50 Million By 2031

By Author: Rutuja kadam
Total Articles: 237
Comment this article

Meticulous Research®—a leading global market research company, published a research report titled ‘Saudi Arabia Next Generation Sequencing (NGS) Market Size, Share, Forecast, & Trends Analysis by Offering (Sample Preparation (DNA Extraction, Library Preparation), Instruments) Type (SMRT, DNB) Application (Clinical, Research) End User–Forecast to 2031. According to this latest publication from Meticulous Research®, the Saudi Arabia NGS market is expected to reach $50.0 million by 2031, at a CAGR of 10.1% from 2024 to 2031.

The growth of this market is driven by the rising number of cancer cases, increasing pharmaceutical R&D expenditures, and the surge in genome mapping programs are factors driving the growth of the Saudi Arabia NGS market. However, the high costs of NGS systems and consumables, data confidentiality concerns, the availability of alternative technologies, the low chances of identifying positive, actionable biomarkers, and ethical & legal issues related to NGS-based diagnosis restrain the growth of this market

In addition, increasing adoption of NGS tools among hospitals and clinical ...
... laboratories and government initiatives supporting large-scale genomic sequencing projects are expected to offer growth opportunities for market players. However, the shortage of skilled professionals, issues related to data storage, handling, interpretation, and confidentiality, and concerns about regulatory standards and standardization in diagnostic testing are some of the challenges impacting the market's growth.

Key Players:

Some of the key players operating in Saudi Arabia NGS market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Revvity, Inc. (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Pacific Biosciences of California, Inc. (U.S.), Danaher Corporation (U.S.), Oxford Nanopore Technologies Plc. (U.K.), Beijing Genomics Institute (BGI) (China), Bio-Rad Laboratories, Inc. (U.S.), and 10x Genomics, Inc. (U.S.).

The Saudi Arabia NGS market is segmented by Offering, Sequencing Type, Application, and End User.

Among the offerings studied in this report, in 2024, the consumables segment is anticipated to dominate the Saudi Arabia NGS market, with a share of 62.6%. The consumables segment is further segmented into sample preparation consumables and sequencing consumables. The sample preparation consumables segment is further categorized into library preparation & target enrichment, DNA extraction & amplification, quality control, and other kits & reagents. In 2024, the library preparation & target enrichment segment is anticipated to dominate the market, with a share of 45.0%. Library preparation solutions provide an end-to-end solution for all library construction steps, such as fragmentation, amplification, adapter ligation, enrichment, and barcoding, contributing to their increased demand in clinical and research settings. Target enrichment enables researchers to enrich specific genes, exons, or genomic regions of interest. It allows the sequencing of regions that are of interest, resulting in reduced time for sequencing and cost savings.

Among the sequencing types studied in this report, in 2024, the targeted genome sequencing segment is anticipated to dominate Saudi Arabia NGS market. Targeted sequencing minimizes the generation of irrelevant genetic variation, which can obscure or complicate clinical interpretation. Additionally, it significantly reduces the cost of sequencing compared to whole genome sequencing (WGS) and whole exome sequencing (WES), particularly when sequencing large populations. Moreover, this technology has facilitated the study of gene-drug associations, aiding in the design of gene-specific drugs with higher precision, thus increasing its adoption.

Among the applications studied in this report, in 2024, the research & other applications segment is anticipated to dominate Saudi Arabia NGS market, with a share of 56.9%. The research & other applications segment is further divided into cancer research, genetic disease research, cell & molecular biology research, microbiology & infectious disease research, agriculture & animal research, and other applications. In 2024, the cancer research segment is anticipated to dominate the market, with a share of 49.4%. The rising cancer incidence, increasing need for novel therapies for cancer treatment, and rising emphasis on personalized cancer therapies are factors contributing to the large market share of this segment. A single NGS-based test can often substitute multiple single-gene tests or small hotspot panels, allowing for the analysis of a wide range of clinically actionable cancer biomarkers in less time, which contributes to its rising adoption.

Among the end users studied in this report, in 2024, the hospitals & diagnostic laboratories segment is anticipated to dominate Saudi Arabia NGS market. In recent years, hospitals and diagnostic laboratories have become major end users of next-generation sequencing technology. The adoption of these technologies has increased in clinical diagnostics, a trend expected to continue as sequencing costs decline, making the technology more accessible to a broader range of healthcare providers. Additionally, Saudi Arabia’s Vision 2030 policy includes initiatives to conduct genetic testing locally and to digitalize diagnostic laboratories. These supportive government policies contribute to the large market share of this segment.

Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=6002

Key Questions Answered in the Report:

What is the revenue generated from the sales of NGS instruments, consumables, and software in Saudi Arabia?
At what rate is the demand for NGS solutions & services projected to grow for the next five to seven years?
What is the historical market size and growth rate for the Saudi Arabia NGS market?
What are the major factors impacting the growth of the Saudi Arabia NGS market?
What are the major opportunities for existing players and new entrants in the market?
Which offering and end user segments are anticipated to create major traction for market players?
What are the key trends in this market?
Who are the major players in the Saudi Arabia NGS market? What are their specific offerings in this market?
What recent developments have taken place in the Saudi Arabia NGS market? What are the impacts of these strategic developments on the market?

Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research